下调和上调
癌症研究
细胞生长
小RNA
基因沉默
癌变
异位表达
细胞周期蛋白D1
肝细胞癌
细胞周期蛋白E1
生物
基因敲除
细胞培养
细胞凋亡
细胞
基因表达
癌症
竞争性内源性RNA
细胞周期
基因
遗传学
作者
Binhui Xie,He Xiao,Rui‐Xi Hua,Bing Zhang,Guangming Tan,Sheng Xiong,Liangshuai Liu,Wei Chen,Jun Yang,Xiao-Nong Wang,Heping Li
出处
期刊:Cancer Biomarkers
[IOS Press]
日期:2016-03-30
卷期号:16 (3): 405-413
被引量:52
摘要
microRNAs (miRNAs) dysregulation is widely involved in cancer progression and contributed to sustained cell proliferation by directly targeting multiple targets. Therefore, better understanding the underlying mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy. In our study, we found that mir-765 is upregulated in both hepatocellular carcinoma (HCC) cell lines and tissues, compared to human normal liver cell line and adjacent non-cancerous tissues, respectively. Overexpression of mir-765 increased HCC cells proliferation and tumorigenicity, whereas inhibition of mir-765 reverses this effect. Furthermore, we demonstrated that INPP4B as a direct target of mir-765 and ectopic expression of mir-765 repressed INPP4B expression, resulting in upregulation of p-AKT, Cyclin D1, and downregulation of p-FOXO3a, p21 expression in HCC. Strikingly, we found that silencing the expression of INPP4B is the essential biological function of miR-765 during HCC cell proliferation. Collectively, our findings reveal that miR-765 is a potential onco-miR that participates in carcinogenesis of human HCC by suppressing INPP4B expression, and might represent a potential therapeutic target for HCC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI